Product Program year 2025 Source: CMS Open Payments

EverCross

Device Percutaneous Transluminal Angioplasty (PTA) Balloons

PDI 00763000184360

Open in the dashboard

General payments

$7,432

115 payments

Research payments

$101,063

5 payments

Through program year 2025, $7,432 in general payments and $101,063 in research payments were reported against EverCross (Percutaneous Transluminal Angioplasty (PTA) Balloons).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

6 rows
Year Kind Amount Payments
2025 General $6,177 30
2025 Research $101,063 5
2024 General $326 17
2023 General $603 41
2022 General $229 22
2021 General $98 5

Breakdown

Who paid General payments · program years 2021–2025
  1. Medtronic, Inc. $7,432 115 payments
Top recipients General payments · program year 2025
  1. Brian Derubertis Vascular Surgery · New York, NY $2,250 36% · 2 payments
  2. Jeffrey Carr Interventional Cardiology · Tyler, TX $1,313 21% · 1 payment
  3. Nicole Ilonzo Vascular Surgery · Brooklyn, NY $813 13% · 1 payment
  4. Sahil Parikh Interventional Cardiology · New York, NY $750 12% · 1 payment
  5. Iftekhar Baig Cardiovascular Disease · Bradenton, FL $563 9% · 1 payment

The top 5 of 22 recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Vascular Surgery Surgery $3,329 54% · 8 practitioners
  2. Interventional Cardiology Internal Medicine $2,063 33% · 2 practitioners
  3. Cardiovascular Disease Internal Medicine $596 10% · 3 practitioners
  4. Vascular & Interventional Radiology Radiology $53 <1% · 3 practitioners
  5. Physician Assistant, Surgical Physician Assistant $45 <1% · 2 practitioners

The top 5 of 8 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $2,290 37% · 4 recipients
  2. New York $1,740 28% · 3 recipients
  3. Texas $1,313 21% · 1 recipient
  4. Florida $563 9% · 1 recipient
  5. South Carolina $206 3% · 11 recipients

The top 5 of 6 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

115 general · 5 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record